Pre-market hot trades in US stocks: Ensysce Biosciences pre-market down 9.37%; U-BX Tech pre-market down 9.33%
I'm LongbridgeAI, I can summarize articles.Ensysce Biosciences pre-market down 9.37%; U-BX Tech pre-market down 9.33%; Jet.AI pre-market up 894.15%; Kustom ENT pre-market up 89.11%; Aehr Test Systems pre-market up 30.29%
Popular Pre-Market Trades in U.S. Stocks
Ensysce is down 9.37% in pre-market trading. There are no significant recent news; trading is active with clear capital flow. Considering sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation. no_news
U-BX Tech is down 9.33% in pre-market trading, with no significant recent news. Trading is active with clear capital flow. Considering sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation.
Top Gainers in U.S. Pre-Market Trading
Jet.AI is up 894.15% in pre-market trading. Based on recent news,
-
On July 13, Jet.AI Inc. completed its merger with flyExclusive, Inc. This merger was approved at a special shareholder meeting, marking the collaboration of two key companies, and this significant event has had a notable impact on the market.
-
On July 14, Jet.AI Inc. announced details regarding the completion of the merger and emphasized the importance of this merger for the company's future development.
-
On July 14, the market expressed caution regarding Jet.AI Inc.'s forward-looking statements. Although the company identified and addressed significant risks and uncertainties in its latest annual report and subsequent reports, investors should remain cautious about these statements. The technology sector has performed strongly recently, and the merger event has attracted market attention.
Kustom ENT is up 89.11% in pre-market trading, with no significant recent news. Trading is active with clear capital flow. Considering sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation.
Aehr Test Systems is up 30.29% in pre-market trading. Based on recent news,
-
On July 14, Aehr Test Systems reported a fourth-quarter adjusted net income of $1.391 million, far exceeding the market expectation of -$212,000. This performance significantly boosted market confidence, driving the stock price up.
-
On July 14, the company announced a backlog of orders of $80.6 million as of May 29, with valid backlog orders of $100.6 million since May 29. Strong order backlog and growing demand indicate significant future growth, further boosting the stock price.
-
On July 14, the company projected that revenue for the fiscal year 2027 would be between $130 million and $150 million, well above analysts' expectations of $85.13 million. This optimistic revenue forecast has enhanced investor confidence, driving the stock price significantly higher. Strong demand for AI processors and silicon photonics is driving industry growth